Bruce Holland: Ex Vivo Assessment of ActiGraft Clot Formation Under Anticoagulation
Bruce Holland, Independent Sales Representative at Legacy Medical Consultants, shared RedDress Medical’s post on LinkedIn:
“An important practical question for clinicians: how might stable clot formation under therapeutic anticoagulation affect confidence in considering ActiGraft for appropriate patients?
I’d be interested to hear how wound-care teams are thinking about this evidence.”
RedDress Medical shared a post on LinkedIn about a recent article by Barry Frank Jacobson et al, published in Journal of Thrombosis and Thrombolysis, adding:
“For a technology built on coagulation, demonstrating complete, stable clot formation under therapeutic anticoagulation is a clinically meaningful finding.
In a peer-reviewed ex vivo study, ActiGraft consistently formed complete, stable clots using blood from patients receiving warfarin or rivaroxaban.
More evidence.
More practical answers.
More confidence in where ActiGraft can be used.”
Title: Autologous whole blood clot formation with actigraft in patients receiving oral anticoagulant therapy: an ex vivo feasibility study
Authors: Barry Frank Jacobson, Elise Schapkaitz, Melanie Mc Cree
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience